GILD | Gilead Sciences Inc
Category: Biotechnology company
Quick infos Headquarters: Foster City, California, United States Trade prices Volume: 5.7M Market Cap: 78.22B Prev closed: 59.05 Open: 58.44 High: 61.45 Low: 58.18 52 week low: 57.04 52 week high: 85.97 Dividends: Next ER: August 4, 2022
About the Company Gilead Sciences is an American biopharmaceutical company that discovers, develops and commercializes drugs.
Earnings History Date EPS / Forecast Revenue / Forecast July 27, 2022 April 28, 2022 2.12 / 1.86.59B / 6.28BBeat! February 1, 2022 0.69 / 1.597.24B / 6.61BBeat! October 28, 2021 2.65 / 1.767.42B / 6.29BBeat! July 29, 2021 1.87 / 1.746.22B / 6.08BBeat! view more
Historical Data Date Price Open High Low Vol Change ER Aug 17, 2022 66.02 65.97 66.89
65.82
6.44M -0.47% Aug 16, 2022 66.33 66.16 66.42
65.65
7.06M 0.18% Aug 15, 2022 66.21 63.85 66.30
63.66
12.38M 5.16% Aug 12, 2022 62.96 62.71 62.99
62.15
4.00M 0.82% Aug 11, 2022 62.45 62.78 63.41
62.37
5.20M -1.09% Aug 10, 2022 63.14 62.49 63.19
62.11
8.25M 1.84% Aug 9, 2022 62.00 61.58 62.05
61.38
5.15M 0.65% Aug 8, 2022 61.60 61.00 61.71
60.81
5.86M 0.83% Aug 5, 2022 61.09 61.79 61.84
60.62
6.04M -1.32% Aug 4, 2022 61.91 62.14 62.99
61.83
5.51M -0.58% view more
NASDAQ - Nasdaq Stock Market
More profiles and info about the company ISIN: US3755581036 CUSIP: 375558103 Founded:June 1987 Employees:9,000 News
Gilead lifts 2021 guidance as remdesivir sales more than double in Q3 seekingalpha.com Oct 29, 2021 4:28 am Gilead and Merck ink collaboration agreement for Keytruda/Trodelvy breast cancer study seekingalpha.com Oct 29, 2021 4:19 am Gilead Sciences EPS beats by $0.87, beats on revenue, boost FY21 outlook seekingalpha.com Oct 29, 2021 4:04 am
Gilead Earnings Top Views; Biotech Giant Narrows Guidance investors.com Jul 30, 2021 4:14 pm
Gilead Sciences to Release Second Quarter 2021 Financial Results on Thursday, July 29, 2021 finance.yahoo.com Jul 30, 2021 4:05 pm
Workers sue over mandatory COVID-19 vaccination finance.yahoo.com Jul 30, 2021 3:20 pm
Likelihood of reaching herd immunity at this point is fairly low: Epidemiologist finance.yahoo.com Jul 30, 2021 2:51 pm Gilead Sciences Q3 2021 Earnings Preview seekingalpha.com Oct 28, 2021 3:15 am Gilead Sciences/Merck initiate mid-stage islatravir/lenacapavir HIV study seekingalpha.com Oct 26, 2021 7:04 pm FDA approves Gilead Sciences' HIV treatment Biktarvy for expanded indication seekingalpha.com Oct 18, 2021 8:11 pm EMA advisory panel recommends approval of Gilead's Trodelvy for breast cancer seekingalpha.com Oct 15, 2021 8:31 pm Merck data for coronavirus pill pressures developers of antibody therapies seekingalpha.com Oct 1, 2021 10:30 pm Gilead company Kite seeks U.S. label expansion of Yescarta in large B-cell lymphoma seekingalpha.com Oct 1, 2021 5:08 am House Judiciary Committee approves bill to expedite biosimilar drugs to market seekingalpha.com Oct 1, 2021 2:01 am Health Canada approves Gilead's breast cancer treatment Trodelvy seekingalpha.com Sep 28, 2021 4:43 am New guidelines call for Gilead's Trodelvy for second-line triple-negative breast cancer seekingalpha.com Sep 28, 2021 12:43 am Matinas BioPharma gains 16% on Gilead remdesivir data seekingalpha.com Sep 23, 2021 3:59 am Gilead data shows remdesivir cuts hospitalization risk in at-risk COVID patients seekingalpha.com Sep 22, 2021 9:19 pm NanoViricides surges 60% on COVID remdesivir encapsulation data seekingalpha.com Sep 22, 2021 2:01 am European study questions benefit of Gilead's remdesivir for hospitalized COVID patients seekingalpha.com Sep 17, 2021 8:55 pm GILD Dividends Ex-Dividend Amount Announced Date Record Date Payment Date Sep 14, 2022 0.73 Sep 29, 2022 Jun 14, 2022 0.73 Jun 29, 2022 Mar 14, 2022 0.73 Mar 30, 2022 Dec 14, 2021 0.71 Dec 30, 2021 Sep 14, 2021 0.71 Sep 29, 2021 view more
Key Persons CEO : John F. Milligan, PhD Talk about Gilead Sciences Inc below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
If you are looking for News & events, Press Release, they are available on their Investors Relations site.
Homepage: gilead.com Consensus
If you want to help pay for server cost or for improving this tool. You can send it via Paypal .
Buy on Amazon Technical analysis is a collection of techniques designed to help you make trading decisions in securities markets. Technical Analysis For Dummies helps you take a hard-headed look at what securities prices are actually doing rather than what economists or analysts say they should be doing, giving you the know-how to use that data to decide whether to buy or sell individual securities.
A simple, straightforward guide to the fundamentals of technical analysis
